Opendata, web and dolomites

MegaALS SIGNED

Unravelling the Interplay between Metabolism, Gut Microbiome and Adaptive Immunity in Amyotrophic Lateral Sclerosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MegaALS project word cloud

Explore the words cloud of the MegaALS project. It provides you a very rough idea of what is the project "MegaALS" about.

fecal    strategy    lack    physiology    warranted    usefulness    leads    combining    lifestyle    effectiveness    possibility    mouse    offers    siblings    disorder    immunity    caloric    population    death    transplant    als    donors    amyotrophic    profiles    prevention    tested    therapeutic    systemic    hypothesize    contributes    explore    human    preventive    platforms    adaptive    microbiome    regimen    healthy    profiling    molecular    individuals    risk    quality    multiple    observational    diet    substantially    gut    metagenomic    mechanisms    interplay    sod1g93a    central    treatments    devastating    proteomic    lateral    disease    diagnosis    understand    stockholm    intervention    compare    rare    treatment    combines    unrelated    microbiota    significantly    translate    sclerosis    metabolism    few    specificity    spouses    immune    controls    first    ultimate    contrast    physiological    nervous    overarching    environmental    epidemiological    experimental    interactions    model    underlying    neurodegenerative    innovative    etiopathogenesis    uses    animal   

Project "MegaALS" data sheet

The following table provides information about the project.

Coordinator
KAROLINSKA INSTITUTET 

Organization address
address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177
website: www.ki.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 1˙499˙196 €
 EC max contribution 1˙499˙196 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET SE (STOCKHOLM) coordinator 1˙499˙196.00

Map

 Project objective

Amyotrophic lateral sclerosis (ALS) is a rare but devastating neurodegenerative disorder that in lack of effective treatments leads to death within a few years of diagnosis. ALS is increasingly being recognized as a systemic disease affecting not only the central nervous system but also other physiological aspects. We hypothesize that there is a disease-specific interplay between metabolism, gut microbiome and adaptive immunity, which substantially contributes to the etiopathogenesis of ALS. The overarching aim of this project is therefore to explore such interplay, and to assess the effectiveness of a treatment regimen that specifically targets it. Using a population-based case-control study of ALS in Stockholm, I will first characterize the complex interactions between metabolism, microbiome, and immunity in ALS, through comprehensive proteomic, metagenomic and immune-response profiling. The specificity of these interactions will be tested in contrast to healthy individuals at high risk for ALS (siblings), individuals with similar environmental and lifestyle factors (spouses), and unrelated population-controls. I will then use an established ALS mouse model (SOD1G93A) to understand the usefulness of combining a high-caloric diet with a fecal microbiota transplant from healthy human donors in disease prevention and treatment. To better understand the underlying mechanisms, I will compare microbiome and immune-response profiles before and after the intervention. The proposed research is unique as it 1) combines innovative molecular platforms with a high-quality epidemiological study design, 2) uses a novel strategy of investigating multiple aspects of human physiology, and 3) offers a possibility to directly translate findings between human observational and animal experimental studies. The ultimate goal is to significantly advance our knowledge about ALS as a disease, and more importantly to identify novel and highly warranted preventive and therapeutic targets.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEGAALS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEGAALS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

PonD (2019)

Particles-on-Demand for Multiscale Fluid Dynamics

Read More  

ENUF (2019)

Evaluation of Novel Ultra-Fast selective III-V Epitaxy

Read More  

CARBYNE (2020)

New carbon reactivity rules for molecular editing

Read More